Response rate to treatment Up to 1 year at most [clinicaltrials_resource:f371acec4e264f8806e7e652924907bf]
A 30% response rate (complete or partial response) to treatment is expected. The response will be assessed according to RECIST criteria. This primary outcome measure is defined by the observation of at least one objective response during the treatment.
This outcome measure will be correlated to biological factors.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Response rate to treatment Up to 1 year at most [clinicaltrials_resource:f371acec4e264f8806e7e652924907bf]
A 30% response rate (complete or partial response) to treatment is expected. The response will be assessed according to RECIST criteria. This primary outcome measure is defined by the observation of at least one objective response during the treatment.
This outcome measure will be correlated to biological factors.
Bio2RDF identifier
f371acec4e264f8806e7e652924907bf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f371acec4e264f8806e7e652924907bf
measure [clinicaltrials_vocabulary:measure]
Response rate to treatment
time frame [clinicaltrials_vocabulary:time-frame]
Up to 1 year at most
description
A 30% response rate (complete ...... related to biological factors.
identifier
clinicaltrials_resource:f371acec4e264f8806e7e652924907bf
title
Response rate to treatment Up to 1 year at most
@en
type
label
Response rate to treatment Up ...... 1acec4e264f8806e7e652924907bf]
@en